Amsilarotene

Drug Profile

Amsilarotene

Alternative Names: Am-555S; TAC-101

Latest Information Update: 08 Apr 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Taiho Pharmaceutical
  • Class Antineoplastics; Benzoic acids; Retinoids; Small molecules
  • Mechanism of Action Angiogenesis inhibitors; Retinoic acid receptor alpha antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Hepatocellular carcinoma

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 17 Mar 2011 Discontinued - Phase-II for Hepatocellular carcinoma in Italy (PO)
  • 17 Mar 2011 Discontinued - Phase-II for Hepatocellular carcinoma in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top